BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 15080301)

  • 21. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
    Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
    Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
    Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24.
    Stachurski D; Miron PM; Al-Homsi S; Hutchinson L; Harris NL; Woda B; Wang SA
    Hum Pathol; 2007 Jun; 38(6):940-5. PubMed ID: 17509395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometry-based proteomic studies of human anaplastic large cell lymphoma.
    Lim MS; Elenitoba-Johnson KS
    Mol Cell Proteomics; 2006 Oct; 5(10):1787-98. PubMed ID: 16785248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma.
    Morris SW; Xue L; Ma Z; Kinney MC
    Br J Haematol; 2001 May; 113(2):275-95. PubMed ID: 11380391
    [No Abstract]   [Full Text] [Related]  

  • 26. ALK-positive Large B-cell Lymphoma: A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature.
    Pan Z; Hu S; Li M; Zhou Y; Kim YS; Reddy V; Sanmann JN; Smith LM; Chen M; Gao Z; Wang HY; Yuan J
    Am J Surg Pathol; 2017 Jan; 41(1):25-38. PubMed ID: 27740969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in aggressive lymphoma: the contribution of novel biological markers.
    Montserrat E
    Ann Hematol; 2001; 80 Suppl 3():B42-4. PubMed ID: 11757705
    [No Abstract]   [Full Text] [Related]  

  • 28. Emerging Roles of ALK in Immunity and Insights for Immunotherapy.
    Wang L; Lui VWY
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32059449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma.
    Liang X; Meech SJ; Odom LF; Bitter MA; Ryder JW; Hunger SP; Lovell MA; Meltesen L; Wei Q; Williams SA; Hutchinson RN; McGavran L
    Am J Clin Pathol; 2004 Apr; 121(4):496-506. PubMed ID: 15080301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count.
    Nguyen JT; Condron MR; Nguyen ND; De J; Medeiros LJ; Padula A
    Pathol Int; 2009 May; 59(5):345-53. PubMed ID: 19432678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature.
    Onciu M; Behm FG; Raimondi SC; Moore S; Harwood EL; Pui CH; Sandlund JT
    Am J Clin Pathol; 2003 Oct; 120(4):617-25. PubMed ID: 14560573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anaplastic lymphoma kinase in the pathogenesis of cancer.
    Chiarle R; Voena C; Ambrogio C; Piva R; Inghirami G
    Nat Rev Cancer; 2008 Jan; 8(1):11-23. PubMed ID: 18097461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia.
    Lim JH; Jang S; Park CJ; Cho YU; Lee JH; Lee KH; Lee JO; Shin JY; Kim JI; Huh J; Seo EJ
    Cancer Genet; 2014; 207(1-2):40-5. PubMed ID: 24613277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timely topic: anaplastic lymphoma kinase (ALK) spreads its influence.
    Cheuk W; Chan JK
    Pathology; 2001 Feb; 33(1):7-12. PubMed ID: 11280613
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.